In vitro effect of lithium chloride on interleukin-15 production by monocytes from breast cancer patients

Journal of Chemotherapy

Volumn 12, Issue 3, 2000, Pages 252-257

  Merendino, Rosaria Alba ^a   Arena, A ^b   Gangemi, S ^b   Ruello, A ^b   Losi, E ^b   Bene, A ^b   Valenti, A ^a   Purello D'Ambrosio, F ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b Università di Messina ^*

Author keywords

Breast cancer; IL 15; Interleukin; Lithium chloride; Monocyte

Indexed keywords

CYTOKINE; INTERLEUKIN 15; LIPOPOLYSACCHARIDE; LITHIUM CHLORIDE;

ADULT; AGED; ARTICLE; BREAST CANCER; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; PROTEIN INDUCTION; REGULATORY MECHANISM;

EID: 0008184986     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2000.12.3.252     Document Type: Article

References (34)

1. 1 Stein RS, Howard CA, Brennan M, Czorniak M. Lithium carbonate and granulocyte production: Dose optimization. Cancer 1981; 48: 2696-2701.
2. 2 Boggs DR, Joyce RA. The hematopoietic effects of lithium. Semin Hematol 1983; 20: 129-134.
3. 3 Mrozek E, Anderson P, Caligiuri MA. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood. 1996; 87(7): 2632-40.
4. 4 Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency XI bone marrow cells. Blood. 1996; 88 (10): 3901-9.
5. 5 Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 1994; 264: 965-968.
6. 6 Mody CH, Spurrell JC, Wood CJ. Interleukin-15 induces antimicrobial activity after release by Cryptococcus neoformans-stimulated monocytes. J Infect Dis 1998; 178 (3): 803-14.
7. 7 Carson W, Caligiuri MA. Interleukin-15 as a potential regulator of the innate immune response. Braz J Med Biol Res 1998; 31(1): 1-9.
8. 8 Trentin L, Zambello R, Facco M, Sancetta R, Agostini C, Semenzato G. Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. Leuk Lymphoma 1997; 27 (1-2): 35-42.
9. 9 Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. J Immunol 1995; 154: 483-487.
10. 10 Nishimura H, Hiromatsu K, Kobayashi N, et al. IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection. J Immunol 1996; 156: 663-668.
11. 11 Carson WE, Giri JG, Lindemann MJ, et al. Interleukin ( IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180: 1395-1400.
12. 12 Kirman I, Vainer B, Nielsen OH. Interleukin-15 and its role in chronic inflammatory diseases. Inflamm Res 1998; 47(7): 285-289.
13. 13 Takeuchi E, Yanagawa H, Yano S, Haku T, Sone S. Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms. Jpn J Cancer Res 1996; 87 (12): 1251-8.
14. 14 Gamero AM, Ussery D, Reintgen DS, Puleo CA, Djeu JY. Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res 1995; 55 (21): 4988-94.
15. 15 Evans R, Fuller JA, Christianson G, Krupke DM, Troutt AB. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations. Cell Immunol 1997; 179(1): 66-73.
16. 16 Matory YL, Chen M, Dorfman DM, Williams A, Goedegebuure PS, Eberlein TJ. Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection. Surgery 1995; 118(2): 251-56.
17. 17 Maemura M, Iino Y, Horiguchi J, et al. Effects of interferon-alpha on cellular proliferation and adhesion of breast carcinoma cells. Oncol Rep 1999; 6 (3): 557-61.
18. 18 Nelson DS, Nelson M, Farram E, Inoue Y. Cancer and subversion of host defences. Aust J Exp Biol Med Sci, 1981; 59: 229-62.
19. 19 Nelson DS, Nelson M, Inoue Y. Some aspects of macrophage-tumor relationships. In: Macrophage biology. Reichard S, Kojima M, (Ed). Alan R Liss, New York, 1985: 833-44.
20. 20 Arena A. Capozza AB, Orlando ME, et al. In vitro effects of lithium chloride on TNF-α and IL-6 production by monocytes of patients affected by breast cancer. J Chemother 1997; 9: 219-226.
21. 21 Merendino RA, Gangemi S, Misefari A, et al. Interleukin-12 and interleukin-10 production by mononuclear phagocytic cells from breast cancer patients. Immunology Letters (in press).
22. 22 Merendino RA, Mancuso G, Tomasello F, et al. Effects of lithium carbonate on cytokine production in patients affected by breast cancer. J Biol Regulators Homeostatic Agents 1994; 8: 88-91.
23. 23 American Joint Committee on Cancer. Manual for staging of cancer. In: Beahrs O, Hensen D, Hutter R, et al, eds. Manual for staging of cancer. Philadelphia: JB Lippincott, 1992: 149.
24. 24 Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968; 94: 196-202.
25. 25 Daems WTH, Roos D, Van Der Rhee HJ. The subcellular distribution and biochemical properties of peroxidase in monocytes and macrophages. In: Digle JT, Shaw IH, Jacques PJ (ed). Lysosomes in applied biology and therapeutics. Amsterdam: Elsevier North Holland 1979; Vol. 6: 463-514.
26. 26 Merendino RA, Arena A, Iannello D, et al. Evaluation of macrophage antiviral activity in patients affected by neoplasia. Med Oncol Tumor Pharmacother 1988; 5: 191-197.
27. 27 Merendino RA, Arena A, Mancuso G, et al. Modulation of the intrinsic antiviral activity by Escherichia coli endotoxin in macrophages from patients with neoplasia. J Chemother 1991; 3: 16-22.
28. 28 Merendino RA, Arena A, Capozza AB, Chillemi S, Mesiti M. Serum levels of interleukin-10 in patients affected by breast cancer. Immunol Letters 1996; 53: 59-60.
29. 29 Ueda T, Shimada E, Urakawa T. Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 1994; 29: 423-429.
30. 30 Merendino RA, Arena A, Liberto MC, et al. Influence of sera from patients affected by neoplasia on some human macrophage functions. Cancer Detect Prev 1988; 12: 73-80.
31. 31 de Visser KE, Kast WM. Effects of TGF-beta on the immune system: implications for cancer immunotherapy. Leukemia 1999; 13(8): 1188-99.
32. 32 Zou JP, Morford LA, Chougnet C, et al. Human glioma-induced immunosuppression involves soluble factors that alter monocyte cytokine profile and surface markers. J Immunol 1999; 162 (8): 4882-92.
33. 33 Botti C, Seregni E, Ferrari L, Martinetti A, Bombardieri E. Immunosuppressive factors: role in cancer development and progression. Int J Biol Markers 1998; 13(2): 51-69.
34. 34 Santin AD, Hermonat PL, Ravaggi A, Cannon MJ, Pecorelli S, Parham GP. Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol 1999; 20 (3): 177-81.